Absci Corporation (ABSI) Deep Dive Video

Summary

Absci is a zero-shot, AI-designed antibody platform with massive TAM exposure—but the entire equity story hinges on whether ABS-201 delivers real human efficacy in 2026.

View ABSI stock page · Read the ABSI research report

Loading the video player…